Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
about
Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapyEffect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis.Efficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials.A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).
P2860
Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Neoadjuvant dose-dense gemcita ...... sis in triple-negative tumors.
@ast
Neoadjuvant dose-dense gemcita ...... sis in triple-negative tumors.
@en
type
label
Neoadjuvant dose-dense gemcita ...... sis in triple-negative tumors.
@ast
Neoadjuvant dose-dense gemcita ...... sis in triple-negative tumors.
@en
prefLabel
Neoadjuvant dose-dense gemcita ...... sis in triple-negative tumors.
@ast
Neoadjuvant dose-dense gemcita ...... sis in triple-negative tumors.
@en
P2093
P2860
P1433
P1476
Neoadjuvant dose-dense gemcita ...... sis in triple-negative tumors.
@en
P2093
Denise Eme
Fabrice Lecuru
Henri Hofmann
Jacques Medioni
Jean-Marie Andrieu
Marie-Aude Le Frere-Belda
Stéphane Oudard
P2860
P304
P356
10.2165/11591210-000000000-00000
P577
2011-01-01T00:00:00Z